|
Match
|
Document |
Document Title |
|
|
7413747 |
Transdermal therapeutic system for treating Parkinsonism
A transdermal therapeutic system (TTS) comprises a silicone-based polymer adhesive system having distributed therein (−)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino
]-1-naphthalenol...
|
|
|
7399484 |
System and method for providing therapy to an individual
The present invention relates to a patch and method for providing therapy to an individual. The patch and method provide a user or therapist with the flexibility to apply a patch to highly...
|
|
|
7390935 |
Hydrogel vapor dispenser
The present invention includes a patch. The patch includes a main body with a base portion and a vapor emitting portion. The base portion includes a hydrogel comprising a first surface and an...
|
|
|
7384651 |
Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience
A transdermal therapeutic system (TTS), in particular a patch, is described, comprising:
a detachable protective layer; a pressure-sensitive adhesive reservoir layer; and a backing layer...
|
|
|
7384650 |
Skin permeation enhancement composition for transdermal hormone delivery system
A transdermal hormone delivery system (THDS) is disclosed. The THDS is useful for control of fertility and as therapy for a variety of diseases and conditions treatable by robust delivery of...
|
|
|
7351426 |
Polyester/cyanoacrylate tissue adhesive compositions
This invention addresses absorbable cyanoacrylate-based tissue adhesive compositions based primarily on an alkoxy cyanoacrylate combined with one or more alkyl cyanoacrylate(s), a stabilizer...
|
|
|
7344733 |
Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole
The invention relates to an active-ingredient-containing, matrix-controlled transdermal therapeutic system for the use of pramipexole, ropinirole, pharmaceutically acceptable salts thereof or...
|
|
|
7329417 |
Medical dressing comprising an antimicrobial silver compound
A medical dressing comprising a complex of silver and being capable of releasing antimicrobial silver ion activity, the complex comprising silver ion, a transition element of Group IV of the...
|
|
|
7316817 |
Method and device for topical delivery of therapeutic agents to the skin
A composite sheet for delivering therapeutic agents to the skin and method of use is disclosed. The composite sheet comprises a flexible porous polymer for holding and releasing the therapeutic...
|
|
|
7309498 |
Biodegradable absorbents and methods of preparation
A biodegradable microfiber absorbent comprises a substantially homogeneous mixture of at least one hydrophilic polymer and at least one biodegradable polymer. The absorbent can be prepared by an...
|
|
|
7303759 |
Compositions and methods for reducing blood and fluid loss from open wounds
The invention described herein relates to methods for reducing and/or stopping bleeding or fluid loss from open wound, denuded tissue, or burned skin, comprising the step of applying to the open...
|
|
|
7288265 |
Treating viral infection at smallpox vaccination site
An adhesive patch is provided wherein the patch includes a porous backing having a front side and a back side. The patch also includes a therapeutic formulation located on the front side of the...
|
|
|
7276641 |
External plaster containing 4-biphenylacetic acid
An aqueous hot melted type adhesive base material containing 4-biphenylyl acetic acid (BPAA) is provided. The adhesive base material contains constant amounts of BPAA and has good drug...
|
|
|
7276247 |
Crosslinkable hydrophilic materials from reactive oligomers having pendent photoinitiator groups
The present invention provides crosslinkable compositions useful in the preparation of hydrophilic gels, and are prepared from oligomers having pendent hydrophilic, poly(alkylene oxide) groups,...
|
|
|
7273619 |
Transdermal composition of an antivomiting agent
The present invention relates to a transdermal composition of an antivomiting agent, and more particularly to a transdermal composition of an antivomiting agent which can minimize skin irritation...
|
|
|
7270834 |
Pharmaceutical composition comprising dimethylsulfoxide and ozone
A pharmaceutical composition to be externally applied as a topical preparation for treating several diseases, the composition comprising dimethylsulfoxide (DMSO) and ozone. A method for obtaining...
|
|
|
7267829 |
Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
A transdermal delivery system (TDS)for use in treatment of living bodies may be applied as an open (liquid, gel) or closed (patch) article. The TDS is composed of a particular active agent which...
|
|
|
7264823 |
Medical adhesive and methods of tissue adhesion
An adhesive including a mixture of isocyanate capped molecules formed by reacting multi-isocyanate functional molecules with multi-functional precursor molecules including terminal functional...
|
|
|
7262224 |
Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof
A cosmetic composition is shown for rejuvenating the appearance of skin with reduced or minimal potential for skin irritation, in the form of a lotion or cream which includes as a major component...
|
|
|
7258871 |
Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
The invention relates to the use of a dopamine agonist in the form of an agent consisting of at least two spatially discrete compositions, of which one is a transdermal therapeutic system (TTS)...
|
|
|
7256234 |
Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
The present invention is directed to a hybridized polymer matrix, a method of making such, and products incorporating such a matrix. The hybridized polymer matrix comprises a solvent-free polymer...
|
|
|
7250546 |
Adhesive preparations
This invention provides a patch with less skin stimulation, excellent in long time store stability and heat stability and having favorable tack during use. The patch comprising a...
|
|
|
7247315 |
Compositions and medical device for transdermal delivery of a drug and methods of making and using same
The invention relates to transdermal delivery patches comprising a drug-containing drug reservoir wherein the drug reservoir comprises a plasticizer composition selected to adjust the rate of drug...
|
|
|
7244447 |
Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
A method is provided for increasing the permeability of skin or mucosal tissue to transdermally administered nonsteroidal anti-inflammatory drugs (NSAIDs). The method involves use of a specified...
|
|
|
7238849 |
Adhesive dispensing arrangement
An adhesive dispensing arrangement ( 10 ) comprises an adhesive patch ( 12 ), a sachet ( 14 ), a sachet sealing strip ( 16 ), a pair of parallel gauze flaps ( 18 A and 18 B), and a peelable...
|
|
|
RE39588 |
Transdermal drug delivery device
A diffusional drug delivery device is described which can provide for stability of the adhesive and system components, elimination of the initial burst of drug and hence irritation, and to provide...
|
|
|
7198800 |
Compositions and methods
Non-aerosol spray-on skin patch compositions as described comprising at least one substantially water insoluble film forming agent, at least one film plasticizer agent, at least one water soluble...
|
|
|
7197359 |
Compositions for electroporation
The present invention relates to compositions for electroporation which are useful in elevating percutaneous absorbability of drugs, etc. By controlling electrolyte concentration of compositions...
|
|
|
7179483 |
Compositions and methods for transdermal oxybutynin therapy
The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy....
|
|
|
7175853 |
Therapeutic system which can be moisture-activated
This invention provides for a therapeutic system for timed and controlled release of at least one therapeutic active agent to a human or animal organism by diffusion through the skin or mucous...
|
|
|
7169409 |
Method for preventing crystal formation in a dispersion of a liquid in a matrix
An improved method for the manufacture of transdermal drug delivery devices comprising liquid dispersions of a liquid in an aqueous or nonaqueous matrix is disclosed. More particularly, the...
|
|
|
7157097 |
Penetration enhancing and irritation reducing systems
This invention lies in the technology of transdermal and topical drug delivery. In particular, the present invention relates to enhancement of the penetration of transdermally or topically applied...
|
|
|
7153522 |
Sorbefacients and preparations for percutaneous absorption containing the same
Percutaneous sorbefacients comprising hexylene glycol and 1-menthol, more particularly, percutaneous sorbefacients for female hormones or derivatives thereof; and preparations for percutaneous...
|
|
|
7138135 |
Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
Bioadhesive, closed-cell foam film, sustained release, delivery devices for administering an active agent or combination of active agents to a subject are provided. Methods for making such delivery...
|
|
|
7128929 |
Alginate foam compositions
The specification discloses an alginate foam composition dressing which may be prepared with or without a backing. The foam dressing exhibits unique capability in including soluble or insoluble...
|
|
|
7128899 |
Bleaching device comprising a barrier layer and a bleaching composition comprising polyvinylpyrrolidone
A dental bleaching composition comprises a dental bleaching agent and a polyvinylpyrrolidone thickening agent. The bleaching composition may include water, flavoring agents, a basic substance and...
|
|
|
7118761 |
Method for producing a silver-containing wound care device
Wound care devices having a topically applied silver-based antimicrobial finish are provided. The finish comprises at least one silver ion-containing compound and at least one binder compound. The...
|
|
|
7115276 |
Patch with reduced cold flow
The present invention refers to a flat self-adhering plaster having a multi-layer construction and reduced cold flow, characterized in that the layer of adhesive possesses a core of adhesive being...
|
|
|
7097853 |
Matrix for transdermal drug delivery
A transdermal drug delivery device involving a macromonomer-containing acrylate or methacrylate copolymer, a softener, and a drug. Also a pressure sensitive skin adhesive involving a macromonomer...
|
|
|
7094422 |
Topical delivery of antifungal agents
The present invention provides a topical drug delivery system which comprises: a therapeutically effective amount of an antifungal agent; at least one dermal penetration enhancer, which is a safe...
|
|
|
7094421 |
Plaster containing 4-biphenylacetic acid
It is provided the plaster of anti-inflammatory and analgesic, improving the sustained releasing of 4-biphenylacetic acid from the base adhesive material and low skin irritation, by using more than...
|
|
|
7093599 |
Gels, composites, and health care articles
Gel and gel composites health care articles, including masks, pads, blood bags, tubings, male and female tubing connectors, and needle protector sheath.
|
|
|
7087241 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy....
|
|
|
7081252 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy....
|
|
|
7081251 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy....
|
|
|
7081250 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy....
|
|
|
7081249 |
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy....
|
|
|
7076282 |
Bioadhesive compositions and biomedical electrodes containing them
Bioadhesive Compositions which comprise a hydrophobic polymer wherein the concentration of the polymer at the surface of the adhesive is greater than its concentration in the bulk of the adhesive...
|
|
|
7070808 |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
Transdermal drug delivery patches and methods of their production are described. The patches can be made such that the accommodate highly plasticizing drugs such as selegiline and/or the use of...
|
|
|
7063859 |
Barrier film lined backing layer composition and method for topical administration of active agents
A transdermal drug delivery device for topical application of active agents is disclosed. The invention comprises the use of a flexible and soft backing layer, in particular a cellular foam, having...
|